TrialBMC cardiovascular disorders2021

Trimetazidine offers myocardial protection in elderly coronary artery disease patients undergoing non-cardiac surgery: a randomized, double-blind, placebo-controlled trial.

Zhong-Liang Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.